Industry presses to protect IP Incentives

IPHA is pressing the Irish Government and our MEPs to protect the IP incentives regime which is in danger of erosion by proposed legislation in Brussels.

Read more

Sharp Rise in Health Budget But Patients Still Left Waiting For Innovative Medicines - IPHA

As the Government announced the Budget today [Wednesday], the Irish Pharmaceutical Healthcare Association (IPHA) has said it was very disappointing that enough money could not be found in the expanded allocation for health to cover the costs of making new innovative medicines available to patients.

Read more

IPHA ‘Manifesto’ Issues Call To Place Ireland in Top Seven in Europe For Access To New Medicines

Pharmaceutical innovators’ new declaration of strategic priorities urges:

§  Predictable, multi-annual budgeting for innovative medicines, with sustained rise in funding

§  ‘Innovation czar’ for Department of Health to plan for the global wave of pharmaceutical research

§  New era of industry-Government partnership to avert deepening healthcare crisis

 

Read more

New President at IPHA

Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA).

Read more

New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA

Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a report published today [Friday] by EY-DKM, the economic advisory consultants. 

Read more

NEW IPHA DATA SHOWS IRISH PATIENTS DENIED ACCESS TO VITAL CANCER MEDICINES

Irish patients are among the last in western Europe to have access to vital cancer medicines, placing at risk the Government’s target to put Ireland in the top quartile of European countries for cancer survival within the next decade.

 

Read more

Biopharma Industry’s Latest Price Drops Save €15m on Government’s Medicines Bill, says IPHA

Ireland’s research-based pharmaceutical industry is set to save the Government €15 million on medicines by introducing price reductions today [Sunday] for more than 750 packs of innovative medicines

Read more